Kim, H., Im, S., Keam, B., Ham, H. S., Lee, K. H., Kim, T. Y., . . . Noh, D. Y. (2015). ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy. Cancer Sci.
Citação norma ChicagoKim, Hee-Jun, et al. "ABCB1 Polymorphism As Prognostic Factor in Breast Cancer Patients Treated With Docetaxel and Doxorubicin Neoadjuvant Chemotherapy." Cancer Sci 2015.
MLA CitationKim, Hee-Jun, et al. "ABCB1 Polymorphism As Prognostic Factor in Breast Cancer Patients Treated With Docetaxel and Doxorubicin Neoadjuvant Chemotherapy." Cancer Sci 2015.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.